Alcon Inc. ALC
At closeNov 12, 2026, 8:16 AM EST
Pre-market · Nov 12, 8:16 AM ET
- YTD
- -8.06%
- 1 year
- -6.33%
- Market cap
- 34.81B
- Revenue (ttm)
- 10.98B
- Profit margin
- 6.06%
- EPS (ttm)
- 1.37
- Shares out
- 483.40M
- P/E ratio
- 52.89
- Forward P/E
- 18.38
- Dividend
- 0.36
- Ex-dividend date
- May 5, 2026
- YTD return
- -8.06%
- 1-year return
- -6.33%
- Volume
- 4.86M
- Avg volume
- 1.79M
- Open
- 71.70
- Previous close
- 74.06
- Day's range
- 70.34 – 72.54
- 52-week range
- 61.84 – 87.64
- Analysts
- Buy
- Price target
- 81.98 (+13.1%)
- Earnings date
- Feb 23, 2027
5D -4.99 (-6.44%)
Key statistics
- Enterprise value
- 39.16B
- PEG ratio
- 1.29
- Price / sales
- 3.19
- Price / book
- 1.60
- Dividend yield
- 0.49%
- Payout ratio
- 25.59%
- Revenue growth
- 4.70%
- Free cash flow
- 1.59B
- Total cash
- 1.81B
- Total debt
- 5.34B
- Return on equity
- 3.04%
- Short % of float
- 0.00%
- 50-day average
- 67.93
- 200-day average
- 71.76
Analyst view
Consensus: buy
- Target (low)
- 62.00
- Target (mean)
- 81.98
- Target (high)
- 103.00
- Strong buy3
- Buy17
- Hold6
- Sell0
- Strong sell1
Next earnings
Feb 23, 2027
Expected Feb 23, 2027. Consensus EPS estimate 0.93967.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 23, 2027 | Dec 30, 2026 | 0.94 | — | — | — |
| Nov 10, 2026 | Sep 30, 2026 | 0.89 | 0.91 | +0.02 | +2.25% |
| Aug 10, 2026 | Jun 30, 2026 | 0.77 | 0.84 | +0.07 | +9.09% |
| May 5, 2026 | Mar 31, 2026 | 0.80 | 0.85 | +0.05 | +6.25% |
| Feb 24, 2026 | Dec 31, 2025 | 0.79 | 0.78 | -0.01 | -1.27% |
| Nov 11, 2025 | Sep 30, 2025 | 0.77 | 0.79 | +0.02 | +2.60% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2026 | BTIG | reit | Buy | Buy |
| Nov 11, 2026 | Needham | reit | Buy | Buy |
| Nov 2, 2026 | Needham | reit | Buy | Buy |
| Oct 27, 2026 | Keybanc | main | Overweight | Overweight |
| Oct 21, 2026 | Needham | reit | Buy | Buy |
| Oct 12, 2026 | BTIG | main | Buy | Buy |
About Alcon Inc.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Switzerland
- Website
- alcon.com
News
Baird Maintains Outperform on Alcon, Lowers Price Target to $87
NVIDIA To $186? Here Are 10 Top Analyst Forecasts For Thursday
Alcon: 3 Key Takeaways for Long-Term Investors
Alcon Inc. (ALC) Q3 2026 Earnings Call Transcript
ALC's Q3 Earnings Beat, Revenues Miss, '26 Outlook Narrows, Stock Down
Implantable Headwinds Clip Alcon Revenue Pace Despite Solid Premium Lens Gains
Alcon Q3 2026 Earnings Call Transcript
Brightview Posts Downbeat Q4 Results, Joins Astronics, Spire Global And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
Alcon shares fall as tighter eye-care market outlook raises growth concerns
Stock Market Today: Dow Jones, S&P 500 Futures Rise as Bessent Urges US-China to 'De-Risk' — CRWV, RGTI, FNV in Focus
Your note
Sign in to keep a note on ALC — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 2.95% | 14,749,582 | 1.07B | Jun 29, 2026 |
| NORGES BANK | 2.20% | 10,976,697 | 795.26M | Jun 29, 2026 |
| Invesco Ltd. | 2.08% | 10,380,332 | 752.06M | Jun 29, 2026 |
| Bank Of New York Mellon Corporation | 2.03% | 10,136,925 | 734.42M | Sep 29, 2026 |
| Aristotle Capital Management, LLC | 2.00% | 9,979,069 | 722.98M | Jun 29, 2026 |
| AKO Capital LLP | 1.94% | 9,683,004 | 701.53M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund | 1.44% | 7,175,218 | 519.84M | Jul 30, 2026 |
| VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund | 0.95% | 4,758,876 | 344.78M | Jun 29, 2026 |
| iShares Trust-iShares Core MSCI EAFE ETF | 0.75% | 3,735,153 | 270.61M | Sep 29, 2026 |
| ALLSPRING FUNDS TRUST-Allspring Special Mid Cap Value Fund | 0.66% | 3,283,650 | 237.90M | Sep 29, 2026 |
| VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund | 0.58% | 2,918,000 | 211.41M | Jul 30, 2026 |
| MFS SERIES TRUST X-MFS International Intrinsic Equity Fund | 0.48% | 2,417,516 | 175.15M | Aug 30, 2026 |
